» Articles » PMID: 17264222

Amino Acid Repletion Does Not Decrease Muscle Protein Catabolism During Hemodialysis

Overview
Date 2007 Feb 1
PMID 17264222
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Intradialytic protein catabolism is attributed to loss of amino acids in the dialysate. We investigated the effect of amino acid infusion during hemodialysis (HD) on muscle protein turnover and amino acid transport kinetics by using stable isotopes of phenylalanine, leucine, and lysine in eight patients with end-stage renal disease (ESRD). Subjects were studied at baseline (pre-HD), 2 h of HD without amino acid infusion (HD-O), and 2 h of HD with amino acid infusion (HD+AA). Amino acid depletion during HD-O augmented the outward transport of amino acids from muscle into the vein. Increased delivery of amino acids to the leg during HD+AA facilitated the transport of amino acids from the artery into the intracellular compartment. Increase in muscle protein breakdown was more than the increase in synthesis during HD-O (46.7 vs. 22.3%, P < 0.001). Net balance (nmol.min(-1).100 ml (-1)) was more negative during HD-O compared with pre-HD (-33.7 +/- 1.5 vs. -6.0 +/- 2.3, P < 0.001). Despite an abundant supply of amino acids, the net balance (-16.9 +/- 1.8) did not switch from net release to net uptake. HD+AA induced a proportional increase in muscle protein synthesis and catabolism. Branched chain amino acid catabolism increased significantly from baseline during HD-O and did not decrease during HD+AA. Protein synthesis efficiency, the fraction of amino acid in the intracellular pool that is utilized for muscle protein synthesis decreased from 42.1% pre-HD to 33.7 and 32.6% during HD-O and HD+AA, respectively (P < 0.01). Thus amino acid repletion during HD increased muscle protein synthesis but did not decrease muscle protein breakdown.

Citing Articles

Hidden risks associated with conventional short intermittent hemodialysis: A call for action to mitigate cardiovascular risk and morbidity.

Canaud B, Kooman J, Selby N, Taal M, Maierhofer A, Kopperschmidt P World J Nephrol. 2022; 11(2):39-57.

PMID: 35433339 PMC: 8968472. DOI: 10.5527/wjn.v11.i2.39.


Anabolic Resistance of Muscle Protein Turnover Comes in Various Shapes and Sizes.

Paulussen K, McKenna C, Beals J, Wilund K, Salvador A, Burd N Front Nutr. 2021; 8:615849.

PMID: 34026802 PMC: 8131552. DOI: 10.3389/fnut.2021.615849.


Dietary Protein and Physical Activity Interventions to Support Muscle Maintenance in End-Stage Renal Disease Patients on Hemodialysis.

Hendriks F, Smeets J, van der Sande F, Kooman J, van Loon L Nutrients. 2019; 11(12).

PMID: 31817402 PMC: 6950262. DOI: 10.3390/nu11122972.


Optimal nutrition in hemodialysis patients.

Ikizler T Adv Chronic Kidney Dis. 2013; 20(2):181-9.

PMID: 23439378 PMC: 3582995. DOI: 10.1053/j.ackd.2012.12.002.


Sarcopenia: a major challenge in elderly patients with end-stage renal disease.

Domanski M, Ciechanowski K J Aging Res. 2012; 2012:754739.

PMID: 22536505 PMC: 3321443. DOI: 10.1155/2012/754739.